Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials
… Indian … 2 diabetes who are at high risk of cardiovascular and kidney disease. It is also used in people who do not have these comorbidities but have a compelling need to reduce the risk …..... Read More